Form 4: Clene Inc. Director Alison Mosca Granted Stock Options

Alison Mosca, a director of Clene Inc., was granted stock options for 51,399 shares of common stock on June 7, 2024.

Summary

• On June 7, 2024, Alison Mosca, a director of Clene Inc., was granted stock options to purchase 51,399 shares of Clene Inc. common stock.
• The options were granted under the Clene Inc. Amended 2020 Stock Plan.
• The exercise price for the options is $0.37 per share.
• The options vest immediately upon grant and expire on June 6, 2034.
• Following the transaction, Ms. Mosca directly owns 51,399 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a routine event and generally viewed as a positive incentive for company directors.

Positives

• The immediate vesting of the options suggests confidence in the director's continued contribution to the company.
• The grant aligns the director's interests with those of the shareholders, incentivizing her to work towards increasing the company's value.

Industry Context

Stock option grants are a common practice for incentivizing company directors and aligning their interests with those of shareholders. The specifics of the grant, such as the vesting schedule and exercise price, can vary depending on the company's compensation policies and performance goals.

Comparison to Industry Standards

• Stock option grants to directors are a standard practice across the biotechnology industry to align their interests with shareholders.
• The size of the grant (51,399 shares) and the exercise price ($0.37) would need to be compared to similar grants at comparable companies to assess its relative value.
• Companies like BioNTech, Moderna, and Novavax also use stock options as part of their compensation packages for directors and executives.

Stakeholder Impact

• Shareholders may view the option grant as a positive sign, aligning the director's interests with the company's long-term success.
• Employees may see the grant as a sign of confidence in the company's future.

Key Dates